Peptide therapy TikTok claims: what the science actually supports

What's this video probably claiming?

Based on the peptide category and creator context, this video likely promotes one or more peptides, such as BPC-157, TB-500, CJC-1295, ipamorelin, or GHK-Cu, as performance-enhancing or recovery-accelerating compounds. The typical script in this genre goes something like: these peptides are what doctors and athletes use, they're safer than steroids, they heal injuries faster, and they optimize growth hormone. The creator probably frames them as cutting-edge biohacking tools being suppressed or ignored by mainstream medicine. There may be personal anecdote involved, before-and-after framing, or vague appeals to "research" without actually citing any. The category also includes MK-677 and semax, which carry their own distinct claims around cognitive enhancement and IGF-1 elevation. None of this is automatically wrong, but the gap between what rodent studies show and what someone injecting a research-grade peptide in their garage will experience is enormous, and most TikTok creators either don't know that gap exists or choose not to mention it.

What does the science actually show?

The honest answer is: it depends heavily on which peptide you're talking about, and in almost every case, human data is thin. BPC-157 has shown genuine wound-healing and gastroprotective effects in rat models, including a frequently cited 2018 study by Sikiric et al. in Current Pharmaceutical Design, but zero completed randomized controlled trials in humans. TB-500 (thymosin beta-4) accelerated wound closure in a 1999 Philp et al. study and has been explored in cardiac repair contexts, but again, no peer-reviewed human trials for musculoskeletal use. CJC-1295 combined with ipamorelin does measurably increase growth hormone pulse amplitude. A 2006 study by Jetté et al. in Growth Hormone and IGF Research confirmed CJC-1295 sustained GH elevation for up to six days in healthy adults at doses of 30-60 mcg/kg, but linking that GH increase to meaningful body composition changes in already-healthy people is a separate, much harder claim to substantiate. GHK-Cu has legitimate skin and wound literature behind it. MK-677 is not a peptide, it is a ghrelin mimetic taken orally, and long-term data from the MK-677 GHRP trial published by Nass et al. in 2008 in the Journal of Clinical Endocrinology and Metabolism showed increased fasting glucose and insulin resistance alongside any GH benefits.

Where does the social media noise diverge from clinical reality?

The biggest divergence is purity and source. Every peptide being discussed in this category exists in a regulatory gray zone in the United States. The FDA has not approved BPC-157, TB-500, or most of these compounds for human use. What people are injecting comes from research chemical suppliers or compounding pharmacies operating under significant regulatory scrutiny since the FDA's 2023 crackdown on certain compounded peptides. A 2021 analysis published by Cohen et al. in JAMA Internal Medicine found that a substantial proportion of peptide products sold online were mislabeled by concentration. Second, the dosing extrapolated from rodent studies does not translate linearly to humans. A rat study dose of 10 mcg/kg does not simply scale up. Third, the recovery claims are almost always anecdotal. The person on TikTok who healed their torn labrum while on BPC-157 also likely rested, did physical therapy, and ate enough protein. Attribution is the problem. No study has isolated peptide use as the variable in human injury recovery outside of wound-healing contexts.

What should you actually know?

Peptides are not a monolith. Some have genuinely interesting mechanistic science behind them. Some are being actively studied in clinical settings. But the version of peptide therapy being sold on TikTok, self-administered from vials of unknown purity, dosed by feel, and stacked without any bloodwork baseline, is not the same thing as peptide therapy administered through a regulated telehealth provider with physician oversight. If you are considering any of these compounds, the relevant questions are: who manufactured this, what is the purity certificate showing, has a physician reviewed your labs, and do you understand the actual known side effects? MK-677 raises blood glucose. GH secretagogues can worsen insulin sensitivity over time. Semax and selank have minimal English-language clinical literature because most research was conducted in Russia with limited independent replication. The enthusiasm on social media is not matched by the evidence base, and that gap matters when you're deciding what to inject into your body.